Alpha adrenoceptor agonist-induced microcirculatory oscillations are reduced in diabetic neuropathy

Microvascular Research

Volumn 76, Issue 2, 2008, Pages 124-131

  Schmiedel, Ole ^a   Nurmikko, Turo J ^b   Schroeter, Matthias L ^c   Whitaker, Rhiannon ^d   Harvey, John N ^a  

^a WREXHAM MAELOR HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d BANGOR UNIVERSITY   (United Kingdom)

Author keywords

Adrenergic alpha Agonists; Diabetes Mellitus; Fourier Analysis; Laser Doppler Flowmetry; Microcirculation physiopathology; Neuropathyldiabetes; Phenylephrine; Type 2 physiopathology; Vasomotor System physiology

Indexed keywords

PHENYLEPHRINE;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DOPPLER FLOWMETRY; ENDOTHELIUM CELL; FEMALE; HUMAN; IONTOPHORESIS; MALE; MICROCIRCULATION; OSCILLATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; AGED; ALBUMINURIA; ARM; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; FOOT; FOURIER ANALYSIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPEREMIA; HYPOTENSION, ORTHOSTATIC; INSULIN RESISTANCE; LASER-DOPPLER FLOWMETRY; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MICROCIRCULATION; MIDDLE AGED; PHENYLEPHRINE; SENSORY THRESHOLDS; SKIN; VALSALVA MANEUVER;

EID: 49949090078     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2008.04.004     Document Type: Article

References (51)

1. Consensus statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology. Diabetes Care 11 (1988) 592-597
2. Benbow S.J., et al. Flow motion in peripheral diabetic neuropathy. Clin. Sci. (Lond) 88 (1995) 191-196
3. Bernardi L., et al. Reduction of 0.1 Hz microcirculatory fluctuations as evidence of sympathetic dysfunction in insulin-dependent diabetes. Cardiovasc. Res. 34 (1997) 185-191
4. Borgstrom P., et al. Slow-wave flowmotion in rabbit skeletal muscle after acute fixed-volume hemorrhage. Circ. Shock 36 (1992) 57-61
5. Chong P.S., and Cros D.P. Technology literature review: quantitative sensory testing. Muscle Nerve 29 (2004) 734-747
6. Colantuoni A., et al. Superposition of arteriolar vasomotion waves and regulation of blood flow in skeletal muscle microcirculation. Adv. Exp. Med. Biol. 277 (1990) 549-558
7. de Wit C., et al. Myogenic effects enhance norepinephrine constriction: inhibition by nitric oxide and felodipine. Kidney Inter., Suppl. 67 (1998) S122-126
8. Dyck P.J., et al. Limitations of quantitative sensory testing when patients are biased toward a bad outcome. Neurology. 50 (1998) 1213
9. Dyck P.J., et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 22 (1999) 1479-1486
10. Feldman E.L., et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17 (1994) 1281-1289
11. Flynn M.D., et al. Direct measurement of capillary blood flow in the diabetic neuropathic foot. Diabetologia 31 (1988) 652-656
12. Freeman R., et al. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology 60 (2003) 465-470
13. Gerstberger R., et al. Regulatory role of vasoactive peptides in subcutaneous skin microcirculation of the hamster. Int. J. Microcirc. Clin. Exp. 7 (1988) 3-14
14. Haddock R.E., and Hill C.E. Rhythmicity in arterial smooth muscle. J. Physiol. 566 (2005) 645-656
15. Harris N.S. Case records of the Massachusetts General Hospital. Case 24-2006. A 40-year-old woman with hypotension after an overdose of amlodipine. N. Engl. J. Med. 355 (2006) 602-611
16. Koenigsberger M., et al. Role of the endothelium on arterial vasomotion. Biophys. J. 88 (2005) 3845-3854
17. Kumar S., et al. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res. Clin. Pract. 13 (1991) 63-67
18. Kvandal P., et al. Regulation of human cutaneous circulation evaluated by laser Doppler flowmetry, iontophoresis, and spectral analysis: importance of nitric oxide and prostaglandines. Microvasc. Res. 65 (2003) 160-171
19. Lamboley M., et al. Recruitment of smooth muscle cells and arterial vasomotion. Am. J. Physiol., Heart Circ. Physiol. 285 (2003) H562-569
20. Lefrandt J.D., et al. Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathy. Diabetologia 46 (2003) 40-47
21. Low P.A. Testing the autonomic nervous system. Semin. Neurol. 23 (2003) 407-421
22. Mauban J.R., and Wier W.G. Essential role of EDHF in the initiation and maintenance of adrenergic vasomotion in rat mesenteric arteries. Am. J. Physiol. Heart. Circ. Physiol. 287 (2004) H608-616
23. Mauban J.R., et al. Adrenergic stimulation of rat resistance arteries affects Ca(2+) sparks, Ca(2+) waves, and Ca(2+) oscillations. Am. J. Physiol., Heart Circ. Physiol. 280 (2001) H2399-2405
24. Medow M.S., et al. Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome. Circulation 112 (2005) 2611-2618
25. Meijer J.W., et al. Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care 23 (2000) 750-753
26. Melzack R. The short-form McGill Pain Questionnaire. Pain. 30 (1987) 191-197
27. Meyer M.F., et al. Impairment of cutaneous arteriolar 0.1 Hz vasomotion in diabetes. Exp. Clin. Endocrinol. Diabetes 111 (2003) 104-110
28. Minson C.T., et al. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J. Appl. Physiol. 91 (2001) 1619-1626
29. Morris S.J., and Shore A.C. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J. Physiol. 496 Pt 2 (1996) 531-542
30. Nilsson H., and Aalkjaer C. Vasomotion: mechanisms and physiological importance. Mol. Interv. 3 (2003) 79-89 51
31. Okazaki K., et al. Role of endothelium-derived hyperpolarizing factor in phenylephrine-induced oscillatory vasomotion in rat small mesenteric artery. Anesthesiology. 98 (2003) 1164-1171
32. Omote M., and Mizusawa H. Effects of cyclopiazonic acid on phenylephrine-induced contractions in the rabbit ear artery. Br. J. Pharmacol. 111 (1994) 233-237
33. Pham H., et al. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes. Care. 23 (2000) 606-611
34. Podgoreanu M.V., et al. Synchronous rhythmical vasomotion in the human cutaneous microvasculature during nonpulsatile cardiopulmonary bypass. Anesthesiology 97 (2002) 1110-1117
35. Quattrini C., et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56 (2007) 2148-2154
36. Rolke R., et al. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur. J. Pain 10 (2006) 77-88
37. Schroeter M.L., et al. Spontaneous low-frequency oscillations decline in the aging brain. J. Cereb. Blood Flow Metab. 24 (2004) 1183-1191
38. Schroeter M.L., et al. Spontaneous slow hemodynamic oscillations are impaired in cerebral microangiopathy. J. Cereb. Blood Flow Metab. 25 (2005) 1675-1684
39. Shy M.E., et al. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 60 (2003) 898-904
40. Silverman D.G., and Stout R.G. Distinction between atropine-sensitive control of microvascular and cardiac oscillatory activity. Microvasc. Res. 63 (2002) 196-208
41. Silverman D.G., et al. Detection and characterization of cholinergic oscillatory control in the forehead microvasculature in response to systemic alpha-agonist infusion in healthy volunteers. Microvasc. Res. 61 (2001) 144-147
42. Smith A.G., et al. The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J. Neurol. Sci. 228 (2005) 65-69
43. Stansberry K.B., et al. Impaired peripheral vasomotion in diabetes. Diabetes Care 19 (1996) 715-721
44. Stefanovska A., et al. Wavelet analysis of oscillations in the peripheral blood circulation measured by laser Doppler technique. IEEE Trans. Biomed. Eng. 46 (1999) 1230-1239
45. Tee G.B., et al. Dependence of human forearm skin postocclusive reactive hyperemia on occlusion time. J. Pharmacol. Toxicol. Methods 50 (2004) 73-78
46. Tesfaye S., et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39 (1996) 1377-1384
47. Vinik A.I., and Mehrabyan A. Diabetic neuropathies. Med. Clin. North. Am. 88 (2004) 947-999 xi
48. Vinik A.I., et al. Methods for evaluation of peripheral neurovascular dysfunction. Diabetes Technol. Ther. 3 (2001) 29-50
49. Vinik A.I., et al. Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care 24 (2001) 1468-1475
50. Vinik E.J., et al. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes. Technol. Ther. 7 (2005) 497-508
51. Wallace T.M., and Matthews D.R. The assessment of insulin resistance in man. Diabet. Med. 19 (2002) 527-534